T1	CHEM 18 27	clonidina
#1	AnnotatorNotes T1	C0009014; clonidine; Organic Chemical · Pharmacologic Substance
T2	CHEM 355 364	clonidina
#2	AnnotatorNotes T2	C0009014; clonidine; Organic Chemical · Pharmacologic Substance
T3	PROC 59 68	anestesia
#3	AnnotatorNotes T3	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T4	CHEM 73 84	sevoflurano
#4	AnnotatorNotes T4	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T5	PROC 88 110	cirugías de oído medio
#5	AnnotatorNotes T5	C2093310; middle ear surgery; Therapeutic or Preventive Procedure
T6	ANAT 100 110	oído medio
#6	AnnotatorNotes T6	C0013455; middle ear; Body Space or Junction | C1268972; Entire middle ear; Body Part, Organ, or Organ Component
T7	CHEM 166 175	clonidina
#7	AnnotatorNotes T7	C0009014; clonidine; Organic Chemical · Pharmacologic Substance
T8	CHEM 182 200	agente a2-agonista
#8	AnnotatorNotes T8	C1998062; Adenosine A2 Receptor Agonists; Pharmacologic Substance (?)
T9	PROC 282 318	evaluar la relación costeo-beneficio
T10	PROC 325 350	medicación pre-anestésica
#9	AnnotatorNotes T10	C0032924; Preanesthetic Medication; Therapeutic or Preventive Procedure
T11	PROC 383 400	anestesia general
#10	AnnotatorNotes T11	C0002915; General Anesthesia; Therapeutic or Preventive Procedure
T12	CHEM 405 416	sevoflurano
#11	AnnotatorNotes T12	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T13	PROC 463 516	estudio encubierto, aleatorio, controlado con placebo
#12	AnnotatorNotes T13	C0599724; placebo controlled study; Research Activity · Intellectual Product + C0206034; Clinical Trials, Randomized; Research Activity + C0150108; Blinded; Research Activity
T14	PROC 630 637	placebo
#13	AnnotatorNotes T14	C0032042; Placebos; Therapeutic or Preventive Procedure
T15	CHEM 644 653	clonidina
#14	AnnotatorNotes T15	C0009014; clonidine; Organic Chemical · Pharmacologic Substance
T16	PROC 686 706	inducción anestésica
#15	AnnotatorNotes T16	C0853212; Induction of anesthesia; Therapeutic or Preventive Procedure
T17	CHEM 721 732	sevoflurano
#16	AnnotatorNotes T17	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T18	CHEM 734 744	alfentanil
#17	AnnotatorNotes T18	C0002026; alfentanil; Organic Chemical · Pharmacologic Substance
T19	CHEM 760 770	pancuronio
#18	AnnotatorNotes T19	C0030310; pancuronium; Organic Chemical · Pharmacologic Substance
T20	DISO 820 834	complicaciones
#19	AnnotatorNotes T20	C0009566; Complication; Pathologic Function
T21	CHEM 847 858	halogenados
#20	AnnotatorNotes T21	C0018544; Halogens; Element, Ion, or Isotope
T22	PROC 870 879	anestesia
#21	AnnotatorNotes T22	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T23	DISO 1082 1096	complicaciones
#22	AnnotatorNotes T23	C0009566; Complication; Pathologic Function
T24	CHEM 1236 1247	sevoflurano
#23	AnnotatorNotes T24	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T25	PROC 1262 1269	cirugía
#24	AnnotatorNotes T25	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T26	CHEM 1408 1417	clonidina
#25	AnnotatorNotes T26	C0009014; clonidine; Organic Chemical · Pharmacologic Substance
T27	CHEM 1485 1494	clonidina
#26	AnnotatorNotes T27	C0009014; clonidine; Organic Chemical · Pharmacologic Substance
T28	CHEM 1545 1556	sevoflurano
#27	AnnotatorNotes T28	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T29	CHEM 1664 1675	sevoflurano
#28	AnnotatorNotes T29	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T30	PROC 114 134	régimen ambulatorial
#29	AnnotatorNotes T30	C0002423; ambulatory care services; Health Care Activity
T31	CHEM 228 239	anestésicos
#30	AnnotatorNotes T31	C0002932; Anesthetics; Pharmacologic Substance
T32	PROC 420 440	régimen ambulatorial
#31	AnnotatorNotes T32	C0002423; ambulatory care services; Health Care Activity
T33	PROC 1730 1750	régimen ambulatorial
#32	AnnotatorNotes T33	C0002423; ambulatory care services; Health Care Activity
T34	Route 32 42	vía venosa
#33	AnnotatorNotes T34	C1522726; Intravenous Route of Drug Administration; Functional Concept
T35	Route 250 262	inhalatorios
#34	AnnotatorNotes T35	C0205535; Inhalation Route of Drug Administration; Functional Concept
T36	Route 369 379	vía venosa
#35	AnnotatorNotes T36	C1522726; Intravenous Route of Drug Administration; Functional Concept
T37	LIVB 532 541	pacientes
#36	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Age 551 569	entre 15 y 52 años
T39	LIVB 575 584	pacientes
#37	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	Dose 654 663	3 µg.kg-1
T41	Dose 671 680	5 µg.kg-1
T42	Dose 746 756	30 µg.kg-1
T43	Dose 772 784	0,08 mg.kg-1
T45	Dose 1496 1505	3 µg.kg-1
T46	Route 1511 1521	vía venosa
#38	AnnotatorNotes T46	C1522726; Intravenous Route of Drug Administration; Functional Concept
T48	Dose 1618 1627	5 µg.kg-1
T51	PHYS 891 903	recuperación
#39	AnnotatorNotes T51	C2004454; Recovery - healing process; Organism Function
T52	PHYS 1111 1123	recuperación
#40	AnnotatorNotes T52	C2004454; Recovery - healing process; Organism Function
T53	PHYS 1147 1159	recuperación
#41	AnnotatorNotes T53	C2004454; Recovery - healing process; Organism Function
T54	PHYS 1583 1595	recuperación
#42	AnnotatorNotes T54	C2004454; Recovery - healing process; Organism Function
T55	PHYS 1689 1701	recuperación
#43	AnnotatorNotes T55	C2004454; Recovery - healing process; Organism Function
T50	Route 240 247	venosos
#44	AnnotatorNotes T50	C1522726; Intravenous Route of Drug Administration; Functional Concept
T44	Frequency 1248 1258	por minuto
T56	Dose 1274 1285	0.54 ± 0,14
#45	AnnotatorNotes T56	[Dose expressed in milliliters]
T57	Dose 1302 1313	0,33 ± 0,09
#46	AnnotatorNotes T57	[Dose expressed in milliliters]
T58	Dose 1316 1327	0,34 ± 0,13
#47	AnnotatorNotes T58	[Dose expressed in milliliters]
T47	Time 336 350	pre-anestésica
R1	Has_Route_or_Mode Arg1:T1 Arg2:T34	
R2	Used_for Arg1:T1 Arg2:T3	
R3	Used_for Arg1:T4 Arg2:T3	
R4	Before Arg1:T3 Arg2:T5	
R5	Combined_with Arg1:T1 Arg2:T4	
R6	Location_of Arg1:T6 Arg2:T5	
R7	Has_Route_or_Mode Arg1:T31 Arg2:T50	
R8	Has_Route_or_Mode Arg1:T31 Arg2:T35	
R9	Combined_with Arg1:T7 Arg2:T31	
R10	Overlap Arg1:T10 Arg2:T47	
R11	Used_for Arg1:T2 Arg2:T10	
R12	Overlap Arg1:T2 Arg2:T47	
R13	Has_Route_or_Mode Arg1:T2 Arg2:T36	
R14	Used_for Arg1:T2 Arg2:T11	
R15	Used_for Arg1:T12 Arg2:T11	
R16	Combined_with Arg1:T2 Arg2:T12	
R19	Has_Age Arg1:T37 Arg2:T38	
R20	Experiences Arg1:T39 Arg2:T14	
R21	Experiences Arg1:T39 Arg2:T15	
R22	Has_Dose_or_Strength Arg1:T15 Arg2:T40	
R23	Has_Dose_or_Strength Arg1:T15 Arg2:T41	
R24	Used_for Arg1:T17 Arg2:T16	
R25	Combined_with Arg1:T17 Arg2:T18	
R26	Has_Dose_or_Strength Arg1:T18 Arg2:T42	
R27	Combined_with Arg1:T18 Arg2:T19	
R28	Has_Dose_or_Strength Arg1:T19 Arg2:T43	
T49	CONC 860 879	tiempo de anestesia
T59	CONC 881 903	tiempo de recuperación
T60	CONC 1573 1595	tiempo de recuperación
R29	Causes Arg1:T22 Arg2:T20	
R30	Before Arg1:T22 Arg2:T51	
T61	CONC 933 939	gastos
#48	AnnotatorNotes T61	C0220812; Cost aspects; Functional Concept
T62	CONC 950 978	gastos directos e indirectos
#49	AnnotatorNotes T62	C1511972; Direct Costs; Quantitative Concept + C1549766; indirect unit cost; Quantitative Concept
T63	Neg_cue 993 995	No
T64	CONC 1001 1012	diferencias
A1	Assertion T64 Negated
#50	AnnotatorNotes T64	C1705241; Delta (difference); Quantitative Concept
R31	Negation Arg1:T63 Arg2:T64	
T65	CONC 1048 1066	datos demográficos
#51	AnnotatorNotes T65	C4684639; Demographic Data; Intellectual Product
#52	AnnotatorNotes T49	C4724588; anesthesia duration; Temporal Concept
T66	CONC 1099 1134	tiempo para recuperación anestésica
R32	Has_Frequency Arg1:T24 Arg2:T44	
R33	Used_for Arg1:T24 Arg2:T25	
R34	Has_Dose_or_Strength Arg1:T24 Arg2:T56	
R35	Has_Dose_or_Strength Arg1:T24 Arg2:T57	
R36	Has_Dose_or_Strength Arg1:T24 Arg2:T58	
T67	CONC 1422 1428	costeo
#53	AnnotatorNotes T67	C0220812; Cost aspects; Functional Concept
R37	Has_Dose_or_Strength Arg1:T27 Arg2:T45	
R38	Has_Route_or_Mode Arg1:T27 Arg2:T46	
R39	Combined_with Arg1:T27 Arg2:T28	
T68	Neg_cue 1557 1560	sin
T69	Observation 1561 1595	aumentar el tiempo de recuperación
A2	Assertion T69 Negated
R40	Negation Arg1:T68 Arg2:T69	
R41	Causes Arg1:T27 Arg2:T69	
T70	Neg_cue 1712 1714	no
T71	CONC 1715 1726	adecuándose
A3	Assertion T71 Negated
R42	Negation Arg1:T70 Arg2:T71	
#54	AnnotatorNotes T71	C0205411; Adequate; Qualitative Concept
R44	Before Arg1:T29 Arg2:T55	
R45	Before Arg1:T27 Arg2:T54	
T72	CONC 49 55	costeo
#55	AnnotatorNotes T72	C0220812; Cost aspects; Functional Concept
T73	CONC 302 308	costeo
#56	AnnotatorNotes T73	C0220812; Cost aspects; Functional Concept
R46	Before Arg1:T10 Arg2:T11	
A4	Experiencer T37 Patient
A5	Experiencer T39 Patient
